Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Revises Price Target for Foot Locker Based on Market Conditions

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Morgan Stanley analyst Alex Straton reiterated an Equal-Weight rating for Foot Locker (NYSE:FL) but revised the price target down to $26 from $28. The adjustment was made based on the analyst’s evaluation of the company’s performance and prevailing market conditions.

FL Stock Analysis: Near Bottom of 52-Week Range, Investors Cautious About Future Prospects

On March 7, 2024, FL stock closed at $24.34, near the bottom of its 52-week range and below its 200-day simple moving average. The stock saw a modest increase of $0.10, or 0.41%, from the previous close, but dropped $0.04 in after-hours trading. FL’s weak price momentum and position near the bottom of its 52-week range suggest that investors may be cautious about its prospects in the near term. Investors should monitor FL’s performance closely for any potential breakout or further declines.

FL Stock Performance Analysis: Revenue, Net Income, and EPS Decline in 2024

On March 7, 2024, FL stock performance was under scrutiny as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, FL reported a total revenue of $8.17 billion for the past year, which was a decrease of 6.75% compared to the previous year. The total revenue for the fourth quarter was $2.38 billion, which remained flat compared to the previous quarter.

In terms of net income, FL reported a net loss of $330.00 million for the past year, which was a significant decrease of 196.49% compared to the previous year. However, the net loss for the fourth quarter was $389.00 million, which showed no change compared to the previous quarter.

Earnings per share (EPS) for FL were also on a downward trend, with a reported EPS of -$3.50 for the past year, a decrease of 197.82% compared to the previous year. The EPS for the fourth quarter was -$4.12, which showed no change compared to the previous quarter.

Overall, FL stock performance on March 7, 2024, was impacted by the decrease in total revenue, net income, and EPS compared to the previous year. Investors may be concerned about the company’s financial health and future prospects based on these results. It will be important for FL to address these challenges and implement strategies to improve its financial performance in the coming quarters.

Tags: FL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Stock Exchange

Analysts Bullish on BellRing Brands Strong Buy Recommendations and Positive Outlook

Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Westlake Corporation CFO Sells Shares Amid Financial Challenges

Analyst Ratings Show Bullish Sentiments for Boston Scientific

Recommended

Alibaba Stock

Alibaba Shares Face Headwinds Ahead of Quarterly Earnings Release

2 months ago

TakeTwo Interactive Software Inc Faces Stock Decline Due to Disappointing Performance

2 years ago
Occidental Petroleum Stock

Occidental Petroleum’s Strategic Pivot Faces Market Scrutiny

2 days ago
Money Express Stock

Money Express Stock at Critical Juncture Following Acquisition Bid

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

FibroGen Shares Extend Decline Amid Mixed Analyst Outlook

Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

Can Skillsoft Stock Reverse Its Steep Decline?

Trending

Ocuphire Pharma Stock
Analysis

Ocuphire Pharma: A Speculative Surge Defying Financial Fundamentals

by Andreas Sommer
October 12, 2025
0

While Ocuphire Pharma's stock celebrates a spectacular rally, reaching new annual peaks with a stunning 50% surge...

Wolfspeed Stock

Semiconductor Stock Surges Amid Retail Trading Frenzy

October 12, 2025
Hydrofarm Holdings Inc Stock

Hydrofarm Navigates Turbulent Waters Amid Financial Restructuring

October 12, 2025
Rockwell Medical Stock

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

October 12, 2025
US Global Investors Stock

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocuphire Pharma: A Speculative Surge Defying Financial Fundamentals
  • Semiconductor Stock Surges Amid Retail Trading Frenzy
  • Hydrofarm Navigates Turbulent Waters Amid Financial Restructuring

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com